ABSTRACT
Aim of the study: this study aimed to determine the role of prostaglandin E1 on the reduction of the neonatal respiratory morbidity specially [TTN]
Study Design: this is a parallel, randomized placebo controlled trial, comparing the use of Misoprostol [Prostaglandin E[1]] use in the form of Misoprostol E[1] vaginal tablets with nonmedicated similar vaginal tablet [placebo] to decrease the neonatal respiratory distress specially [TTN]
Results: this study included 300 cases with gestational age range between 38 weeks to less than 39 weeks the included cases were classified into 2 groups: study group included 150 case were given PG E1 control group included 150 case were given placebo
Conclusion: we found one positive cases for TTN in study group, and 3 positive cases for TTN in the control group results we got were insignificant. So, we suggested taking larger sample in the future studies